What's Happening?
The EveryLife Foundation for Rare Diseases is showcasing its members and their contributions to advocacy and health equity. Among those featured is Michele Wright, Ph.D., recognized as the 2022 USA TODAY Woman of the Year for Arkansas and a 2022-2023
AARP Purpose Prize Fellow. Dr. Wright, along with her husband Terry Wright, received the Cystic Fibrosis Foundation's 'Breath of Life Award' in 2022, marking them as the first people of color to achieve this honor. Dr. Wright is the CEO and Founder of My Water Buddy® and My Learning Buddy® corporations, which focus on edutainment to promote healthy lifestyles and provide educational platforms for students. She also co-founded and chairs the National Organization of African Americans with Cystic Fibrosis (NOAACF) and co-chairs the annual Blacks, Indigenous, and Other Minority Ethnicities with Rare and Genetic Diseases (BIOMERGD) Conference. Her work includes developing The Wright Cystic Fibrosis Screening Tool© and the Advocating for Health Equity and Addressing Disparities© (AHEAD) Initiative. Additionally, she advocates for 'Terry Wright’s Law,' aimed at improving newborn screening for cystic fibrosis.
Why It's Important?
The work highlighted by the EveryLife Foundation, particularly through individuals like Dr. Michele Wright, is crucial for advancing health equity and addressing disparities in the U.S. healthcare system. Her initiatives directly impact underserved communities, especially those with rare diseases, by increasing awareness, improving diagnostic tools, and advocating for policy changes. The development of The Wright Cystic Fibrosis Screening Tool© and 'Terry Wright’s Law' has the potential to significantly reduce delayed or missed diagnoses for individuals with cystic fibrosis, particularly within BIPOC communities, who have historically faced inequities in healthcare. By promoting edutainment through My Water Buddy® and My Learning Buddy®, Dr. Wright is also fostering healthier lifestyles and educational opportunities for children, contributing to long-term public health improvements. These efforts underscore the ongoing need for targeted advocacy and systemic changes to ensure equitable access to healthcare and accurate diagnoses for all Americans.
What's Next?
The EveryLife Foundation and its advocates will likely continue their efforts to influence policy and raise awareness for rare diseases. The push for 'Terry Wright’s Law' suggests ongoing legislative advocacy to mandate comprehensive newborn screening for cystic fibrosis, which could lead to earlier interventions and improved outcomes for affected individuals. Dr. Wright's organizations, My Water Buddy® and My Learning Buddy®, are expected to expand their reach in promoting health education and social-emotional learning, potentially impacting more children and families across the nation. The BIOMERGD Conference will continue to serve as a vital platform for discussing rare diseases within BIPOC communities, fostering collaboration and driving further research and advocacy. These initiatives indicate a sustained focus on addressing health disparities and ensuring that advancements in medical understanding and policy translate into tangible benefits for all patients.
Beyond the Headlines
The initiatives championed by the EveryLife Foundation and its members delve into the deeper societal challenges of health equity and systemic bias within healthcare. The story of Terry Wright's late diagnosis of cystic fibrosis, despite classic symptoms, highlights how racial and ethnic biases can lead to significant diagnostic delays and poorer health outcomes. This underscores the ethical imperative to re-evaluate diagnostic protocols and medical education to ensure they are inclusive and culturally competent. The focus on edutainment through My Water Buddy® and My Learning Buddy® also points to a broader cultural shift towards proactive health education from a young age, aiming to instill healthy habits and critical thinking skills. These efforts are not just about treating diseases but about fostering a more just and informed society where health outcomes are not predetermined by race or socioeconomic status, ultimately contributing to a more equitable and resilient public health infrastructure in the U.S.
